A new method created by scientists at the Roy Blunt NextGen Precision Health Building brings fresh hope for people fighting blood cancers like lymphoma and leukemia.
Lymphoma
Lymphoma is a general term for localized malignancies that develop in the lymphatic or reticuloendothelial system. Its cells are similar to lymphocytes, plasma cells or histiocytes.Hodgkin’s disease, discovered by Thomas Hodgkin in 1832, is one type of lymphoma. All other lymphomas are grouped together and are called non-Hodgkin’s lymphoma.
Embracing Life’s Unscripted Moments: Sam Neill’s Journey Through Illness and Triumph
Renowned actor Sam Neill has disclosed his battle with an intensely aggressive form of non-Hodgkin lymphoma. The 75-year-old Jurassic Park icon was diagnosed with Stage three cancer in March 2022, believing, “I’m sick, I’m dying.” Unable to pursue acting, Neill turned to writing as a way to pass time and “provide a reason to get through the day,” he shared with the BBC.
GI cancers risk higher among childhood cancer survivors
Study finds high risk of GI cancers among childhood cancer survivors – Survivors of childhood cancers are at an increased risk of another battle with cancer later in life, according to new research published by the Annals of Internal Medicine. Researchers found that childhood cancer survivors develop these malignancies at a rate nearly five times that of the general population.
35 new drugs approved in 2011 in US
FDA: 35 innovative new drugs approved in fiscal year 2011 — Report shows quick approvals of safe and effective medicines occur in the United States before other countries – Over the past 12 months, the U.S. Food and Drug Administration approved 35 new medicines for patients, like two new treatments for hepatitis C; a drug for late-stage prostate cancer; the first new drug for Hodgkin’s lymphoma in 30 years; and the first new drug for lupus in 50 years.
Remicade infliximab approved to treat ulcerative colitis in children
FDA approves Remicade to treat ulcerative colitis in children older than 6 years – The U.S. Food and Drug Administration approved Remicade (infliximab) to treat moderately to severely active ulcerative colitis (UC) in children older than 6 years who have had inadequate response to conventional therapy.
Adcetris approved to treat two types of lymphoma
FDA approves Adcetris to treat two types of lymphoma – The U.S. Food and Drug Administration recently approved Adcetris (brentuximab vedotin) to treat Hodgkin lymphoma (HL) and a rare lymphoma known as systemic anaplastic large cell lymphoma (ALCL).
Breast implants linked to ALCL a rare cancer
FDA review indicates possible association between breast implants and a rare cancer — Agency requesting health care professionals to report confirmed cases – Saline and silicone gel-filled breast implants are linked to anaplastic large cell lymphoma (ALCL), a very rare type of cancer, announced by US Health Agency FDA.
Vitamin D supplements might help lymphoma patients
Mayo Clinic and collaborators find vitamin D levels associated with survival in lymphoma patients – A new study has found that the amount of vitamin D in patients being treated for diffuse large B-cell lymphoma was strongly associated with cancer progression and overall survival.
Cancer mortality declined in Europe
New figures on cancer in Europe show a steady decline in mortality but big variations — Large variations in mortality exist between countries and between men and women – New figures on deaths from cancer in Europe show a steady decline in mortality between the periods 1990-1994 and 2000-2004. Deaths from all cancers in the European Union (EU) between these two periods fell by nine percent in men and eight percent in women, with a large drop among the middle-aged population.
XMRV retrovirus linked to chronic fatigue syndrome
Consortium of Researchers Discover Retroviral Link to Chronic Fatigue Syndrome – A retrovirus named XMRV is frequently present in the blood of patients with chronic fatigue syndrome (CFS), revealed by researchers. This discovery could be a major step in the discovery of vital treatment options for millions of patients.